Serum HMGB1 Serves as a Novel Laboratory Indicator Reflecting Disease Activity and Treatment Response in Ankylosing Spondylitis Patients

Table 3

Baseline characteristics of the two follow-up therapeutic AS groups.

	Anti-TNF	NSAIDs + SASP
	25	16
Age (years)
HMGB1 (ng/mL)
BASDAI
BASFI
ASDAS-CRP
ASDAS-ESR
ESR (mm/h)
CRP (mg/L)